Ligand Pharmaceuticals reported $2.32B in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acceleron Pharma XLRN:US $ 10.52B 2.9B
Acorda Therapeutics ACOR:US $ 51.17M 5.91M
Agenus AGEN:US $ 1.22B 2.65M
Amgen AMGN:US $ 120.75B 19.29B
Anika Therapeutics ANIK:US $ 613.84M 9.15M
Arena Pharmaceuticals ARNA:US $ 3.64B 526.29M
Arrowhead Research ARWR:US $ 6.51B 2.11B
Baxter International BAX:US $ 40.21B 271.8M
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Clovis Oncology CLVS:US $ 528.11M 78.37M
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Eli Lilly And LLY:US $ 221.02B 902.49M
Enanta Pharmaceuticals ENTA:US $ 1.15B 259.62M
Endo International Ordinary Shares ENDP:US 756.54M 335.33M
Flexion Therapeutics FLXN:US $ 306.78M 104.24M
Gilead Sciences GILD:US $ 87.58B 1.22B
Glaxosmithkline GSK:US 95.15B 3.61B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Harsco HSC:US $ 1.34B 274.29M
Heron Therapeutics HRTX:US $ 1.09B 490.97M
Immunogen IMGN:US $ 1.18B 139.17M
Insmed INSM:US $ 3.26B 35.6M
Intrexon XON:US $ 1.03B 314.67M
Karyopharm Therapeutics KPTI:US $ 439.39M 335.56M
Lannett LCI:US $ 126.83M 66.72M
Ligand Pharmaceuticals LGND:US $ 2.32B 138.79M
Macrogenics MGNX:US $ 1.28B 335.6M
Merk MRK:US $ 190131.55M 6786.63M
Pacira Pharmaceuticals PCRX:US $ 2.49B 182M
Pfizer PFE:US $ 241143.67M 21937.97M
Rigel Pharmaceuticals RIGL:US $ 620.19M 118.33M
Sangamo Biosciences SGMO:US $ 1.31B 412.77M
Spectrum Pharmaceuticals SPPI:US $ 357.43M 257.97M
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M
Veracyte VCYT:US $ 3.29B 602.58M